Nissay Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.2M | Buy |
795,895
+26,632
| +3% | +$697K | 0.08% | 166 |
|
|
2026
Q1 | $21.6M | Sell |
769,263
-9,011
| -1% | -$240K | 0.11% | 130 |
|
|
2025
Q4 | $19.4M | Buy |
778,274
+37,961
| +5% | +$957K | 0.1% | 136 |
|
|
2025
Q3 | $18.9M | Sell |
740,313
-23,400
| -3% | -$578K | 0.1% | 138 |
|
|
2025
Q2 | $18.5M | Buy |
763,713
+8,957
| +1% | +$209K | 0.11% | 146 |
|
|
2025
Q1 | $19.1M | Buy |
754,756
+5,692
| +0.8% | +$149K | 0.12% | 125 |
|
|
2024
Q4 | $19.9M | Sell |
749,064
-876
| -0.1% | -$23.8K | 0.12% | 119 |
|
|
2024
Q3 | $21.7M | Buy |
749,940
+12,082
| +2% | +$352K | 0.14% | 112 |
|
|
2024
Q2 | $20.6M | Buy |
737,858
+6,625
| +0.9% | +$182K | 0.14% | 104 |
|
|
2024
Q1 | $20.3M | Sell |
731,233
-6,017
| -0.8% | -$167K | 0.14% | 102 |
|
|
2023
Q4 | $21.2M | Buy |
737,250
+22,079
| +3% | +$667K | 0.17% | 85 |
|
|
2023
Q3 | $23.7M | Buy |
715,171
+6,022
| +0.8% | +$213K | 0.21% | 67 |
|
|
2023
Q2 | $26M | Sell |
709,149
-20,046
| -3% | -$780K | 0.22% | 64 |
|
|
2023
Q1 | $29.8M | Sell |
729,195
-24,384
| -3% | -$1.05M | 0.27% | 66 |
|
|
2022
Q4 | $38.6M | Sell |
753,579
-74,926
| -9% | -$3.59M | 0.37% | 50 |
|
|
2022
Q3 | $36.3M | Buy |
828,505
+25,590
| +3% | +$1.24M | 0.38% | 48 |
|
|
2022
Q2 | $42.1M | Buy |
802,915
+63,855
| +9% | +$3.25M | 0.42% | 37 |
|
|
2022
Q1 | $38.3M | Buy |
739,060
+33,718
| +5% | +$1.75M | 0.33% | 52 |
|
|
2021
Q4 | $41.6M | Sell |
705,342
-44,773
| -6% | -$2.22M | 0.32% | 50 |
|
|
2021
Q3 | $32.3M | Buy |
750,115
+68,948
| +10% | +$3.05M | 0.27% | 58 |
|
|
2021
Q2 | $26.7M | Sell |
681,167
-42,829
| -6% | -$1.67M | 0.23% | 67 |
|
|
2021
Q1 | $26.2M | Buy |
723,996
+6,696
| +0.9% | +$238K | 0.26% | 66 |
|
|
2020
Q4 | $26.4M | Sell |
717,300
-52,455
| -7% | -$1.92M | 0.4% | 56 |
|
|
2020
Q3 | $26.8M | Sell |
769,755
-51,108
| -6% | -$1.79M | 0.45% | 53 |
|
|
2020
Q2 | $25.5M | Buy |
820,863
+119,736
| +17% | +$4.07M | 0.49% | 53 |
|
|
2020
Q1 | $21.7M | Sell |
701,127
-20,826
| -3% | -$710K | 0.55% | 46 |
|
|
2019
Q4 | $26.8M | Sell |
721,953
-53,185
| -7% | -$1.89M | 0.6% | 35 |
|
|
2019
Q3 | $26.4M | Buy |
775,138
+76,815
| +11% | +$2.79M | 0.65% | 34 |
|
|
2019
Q2 | $28.7M | Sell |
698,323
-75,170
| -10% | -$2.98M | 0.73% | 25 |
|
|
2019
Q1 | $31.2M | Sell |
773,493
-23,152
| -3% | -$927K | 0.82% | 21 |
|
|
2018
Q4 | $33M | Buy |
796,645
+22,837
| +3% | +$948K | 1.01% | 14 |
|
|
2018
Q3 | $32.4M | Buy |
773,808
+32,922
| +4% | +$1.27M | 0.87% | 17 |
|
|
2018
Q2 | $25.5M | Sell |
740,886
-90,207
| -11% | -$3.08M | 0.75% | 23 |
|
|
2018
Q1 | $28M | Sell |
831,093
-16,739
| -2% | -$575K | 0.87% | 15 |
|
|
2017
Q4 | $29.1M | Buy |
+847,832
| New | +$28.9M | 0.89% | 15 |
|
Other funds holding PFE
Nissay Asset Management's PFE Position: Q2 2026 in Review
Nissay Asset Management increased its Pfizer (PFE) stake by 3.5% in Q2 2026, buying an estimated $697K and bringing the position to 795,895 shares worth $19.2M. The position accounts for 0.08% of the portfolio, ranked #166.
Nissay Asset Management first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $42.1M in Q2 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Nissay Asset Management held 795,895 shares of Pfizer worth $19.2M as of Q2 2026.
- Nissay Asset Management bought 26,632 Pfizer shares in Q2 2026, an estimated $697K.
- Pfizer made up 0.08% of Nissay Asset Management's portfolio in Q2 2026, its #166 holding.
- Nissay Asset Management first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Nissay Asset Management's Pfizer position peaked at $42.1M in Q2 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Nissay Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.